Alternative Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others), By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others), By End Users (Hospitals and Clinics, Cancer and Radiation Therapy Center, Home Care, Others), By Region and Competition
Global Alternative Cancer Therapeutics market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising aging population, which is susceptible to different types of cancers. Additionally, the growing number of market players, along with growing awareness of new therapies among the aging population, is a major factor that will further drive the growth of the market during the forecast period. Also, the rapidly growing adoption of new therapies such as acupuncture, aromatherapy, yoga, and other alternative therapies for pain management will further drive the growth of the market in the forecast period. Also, growing insurance coverage for alternative cancer treatment, along with growing initiatives by government organizations to educate people about new therapy, will drive the growth of the market over the years.
Growing Prevalence of Cancer
The increasing incidence of adenocarcinoma, lymphoma, and gastrointestinal stromal tumors, lung cancer, breast cancer due to the consumption of alcohol, tobacco, and unhealthy food by the majority of the population across the world is driving the market growth during the forecast period. Similarly, the rising aging population, which is susceptible to chronic diseases like stomach cancer, one of the most common deadly cancers worldwide among older males, will boost the market growth in the forecast period. In 2022 the National Cancer Institute estimated around 26,380 new stomach cancer cases and 11,090 deaths in the United States. In developing countries, stomach cancer is diagnosed more in males than females. The increasing prevalence of gastric cancer across the North American region and also across different parts of the globe has increased the demand for effective therapies for treating patients, which in turn is expected to propel the market growth during the forecast period. For instance, according to the 2021 statistics published by the Canadian Cancer Society, 4,000 Canadians were estimated to develop gastric cancer in 2021. Similarly, growing initiatives by the government to promote the adoption of alternative cancer therapeutics are also boosting the growth of the market over the years. Also, the Ministry of Ayush in India was set up by the government of India to look into matters related to the education, product, and research of naturopathy, Ayurveda, and homeopathy medicines. Therefore, the rising government investments in the growth of alternative therapies is fuelling the demand for various complementary and alternative cancer treatment.
Rising Healthcare Expenditure
Due to the increasing technological developments in the research and development sector in the healthcare industry and the use of alternative therapies in cancer diagnosis, the demand for alternative cancer therapy is expected to create a lucrative growth in the forecast period. Similarly, private and government organizations are supporting the research and development sector with the help of pharmaceutical and biotechnology firms which is further boosting the market growth in the forecast period. The funding for cancer research is rapidly increasing, and most of the government funding is for breast cancer and childhood cancer. In 2019 the National Institutes of Health (NIH) invested USD460 million in breast cancer, which increased to USD3.5 billion in the year 2022.
Market Segmentation
Global alternative cancer therapeutics market can be segmented on therapy type, disease type, end users, region, and competitive landscape. Based on the therapy type, the market can be segmented into Hormone Therapies, Acupuncture, and Dietary Supplements, among Others. Based on Diseases Type, the market can be segmented into Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, and Others. Based on the End Users, the market can be differentiated into Hospitals and Clinics, cancer and Radiation Therapy Centers, Home Care, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global alternative cancer therapeutics market on account of the increasing incidence of different types of cancer in the country.
Recent Development
Innovative Medicine, LLC. , Northwest Natural Health Clinic, Immunotherapy Institute, Georgia Cancer Specialists, Holistic Bio Spa, Johnson & Johnson, Celgene Corporation, Astellas Pharma, Inc., Novartis AG, and Merck KGaA are some of the leading players operating in the Global Alternative Cancer Therapeutics Market.
Report Scope:
In this report, global alternative cancer therapeutics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Alternative Cancer Therapeutics Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Growing Prevalence of Cancer
The increasing incidence of adenocarcinoma, lymphoma, and gastrointestinal stromal tumors, lung cancer, breast cancer due to the consumption of alcohol, tobacco, and unhealthy food by the majority of the population across the world is driving the market growth during the forecast period. Similarly, the rising aging population, which is susceptible to chronic diseases like stomach cancer, one of the most common deadly cancers worldwide among older males, will boost the market growth in the forecast period. In 2022 the National Cancer Institute estimated around 26,380 new stomach cancer cases and 11,090 deaths in the United States. In developing countries, stomach cancer is diagnosed more in males than females. The increasing prevalence of gastric cancer across the North American region and also across different parts of the globe has increased the demand for effective therapies for treating patients, which in turn is expected to propel the market growth during the forecast period. For instance, according to the 2021 statistics published by the Canadian Cancer Society, 4,000 Canadians were estimated to develop gastric cancer in 2021. Similarly, growing initiatives by the government to promote the adoption of alternative cancer therapeutics are also boosting the growth of the market over the years. Also, the Ministry of Ayush in India was set up by the government of India to look into matters related to the education, product, and research of naturopathy, Ayurveda, and homeopathy medicines. Therefore, the rising government investments in the growth of alternative therapies is fuelling the demand for various complementary and alternative cancer treatment.
Rising Healthcare Expenditure
Due to the increasing technological developments in the research and development sector in the healthcare industry and the use of alternative therapies in cancer diagnosis, the demand for alternative cancer therapy is expected to create a lucrative growth in the forecast period. Similarly, private and government organizations are supporting the research and development sector with the help of pharmaceutical and biotechnology firms which is further boosting the market growth in the forecast period. The funding for cancer research is rapidly increasing, and most of the government funding is for breast cancer and childhood cancer. In 2019 the National Institutes of Health (NIH) invested USD460 million in breast cancer, which increased to USD3.5 billion in the year 2022.
Market Segmentation
Global alternative cancer therapeutics market can be segmented on therapy type, disease type, end users, region, and competitive landscape. Based on the therapy type, the market can be segmented into Hormone Therapies, Acupuncture, and Dietary Supplements, among Others. Based on Diseases Type, the market can be segmented into Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, and Others. Based on the End Users, the market can be differentiated into Hospitals and Clinics, cancer and Radiation Therapy Centers, Home Care, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global alternative cancer therapeutics market on account of the increasing incidence of different types of cancer in the country.
Recent Development
- In February 2018, Health Canada approved Janssens Zytiga in combination with prednisone and androgen deprivation therapy for the treatment of patients with newly diagnosed, high-risk metastatic hormone-sensitive prostate cancer who have received up to three months of prior androgen deprivation therapy.
- In April 2020, the US FDA supported Trodelvy (sacituzumab govitecan-hziy) for the therapy of adult patients with triple-negative breast cancer. Trodelvy is a Trop-2-coordinated immunizer and topoisomerase inhibitor drug form which focuses on the Trop-2 receptor that helps cancer develop, separate, and spread.
Innovative Medicine, LLC. , Northwest Natural Health Clinic, Immunotherapy Institute, Georgia Cancer Specialists, Holistic Bio Spa, Johnson & Johnson, Celgene Corporation, Astellas Pharma, Inc., Novartis AG, and Merck KGaA are some of the leading players operating in the Global Alternative Cancer Therapeutics Market.
Report Scope:
In this report, global alternative cancer therapeutics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
- Alternative Cancer Therapeutics Market, By Therapy Type:
- Hormone Therapies
- Acupuncture and Dietary Supplements
- Others
- Alternative Cancer Therapeutics Market, By Disease Type:
- Gastrointestinal
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Leukemia,
- Lymphoma
- Melanoma
- Prostate Cancer
- Others
- Alternative Cancer Therapeutics Market, By End Users:
- Hospitals and Clinics
- Cancer and Radiation Therapy Center
- Home Care
- Others
- Alternative Cancer Therapeutics Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Alternative Cancer Therapeutics Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL ALTERNATIVE CANCER THERAPEUTICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
5.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
5.2.3. By End Users (Hospitals and Clinics, Cancer and Radiation Therapy Center, Home Care, Others)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Product Map
5.3.1. By Therapy Type
5.3.2. By Disease Type
5.3.3. By End Users
5.3.4. By Region
6. NORTH AMERICA ALTERNATIVE CANCER THERAPEUTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
6.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
6.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Alternative Cancer Therapeutics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Therapy Type
6.3.1.2.2. By Disease Type
6.3.1.2.3. By End User
6.3.2. Canada Alternative Cancer Therapeutics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Therapy Type
6.3.2.2.2. By Disease Type
6.3.2.2.3. By End User
6.3.3. Mexico Alternative Cancer Therapeutics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Therapy Type
6.3.3.2.2. By Disease Type
6.3.3.2.3. By End User
7. EUROPE ALTERNATIVE CANCER THERAPEUTICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
7.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
7.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Alternative Cancer Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapy Type
7.3.1.2.2. By Disease Type
7.3.1.2.3. By End User
7.3.2. Germany Alternative Cancer Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapy Type
7.3.2.2.2. By Disease Type
7.3.2.2.3. By End User
7.3.3. United Kingdom Alternative Cancer Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapy Type
7.3.3.2.2. By Disease Type
7.3.3.2.3. By End User
7.3.4. Italy Alternative Cancer Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Therapy Type
7.3.4.2.2. By Disease Type
7.3.4.2.3.
7.3.4.2.4. By End User
7.3.5. Spain Alternative Cancer Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Therapy Type
7.3.5.2.2. By Disease Type
7.3.5.2.3. By End User
8. ASIA-PACIFIC ALTERNATIVE CANCER THERAPEUTICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
8.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
8.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Alternative Cancer Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapy Type
8.3.1.2.2. By Disease Type
8.3.1.2.3. By End User
8.3.2. India Alternative Cancer Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapy Type
8.3.2.2.2. By Disease Type
8.3.2.2.3. By End User
8.3.3. Japan Alternative Cancer Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapy Type
8.3.3.2.2. By Disease Type
8.3.3.2.3. By End User
8.3.4. South Korea Alternative Cancer Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapy Type
8.3.4.2.2. By Disease Type
8.3.4.2.3. By End User
8.3.5. Australia Alternative Cancer Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapy Type
8.3.5.2.2. By Disease Type
8.3.5.2.3. By End User
9. SOUTH AMERICA ALTERNATIVE CANCER THERAPEUTICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
9.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
9.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Alternative Cancer Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapy Type
9.3.1.2.2. By Disease Type
9.3.1.2.3. By End User
9.3.2. Argentina Alternative Cancer Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapy Type
9.3.2.2.2. By Disease Type
9.3.2.2.3. By End User
9.3.3. Colombia Alternative Cancer Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapy Type
9.3.3.2.2. By Disease Type
9.3.3.2.3. By End User
10. MIDDLE EAST AND AFRICA ALTERNATIVE CANCER THERAPEUTICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
10.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
10.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Alternative Cancer Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapy Type
10.3.1.2.2. By Disease Type
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Alternative Cancer Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapy Type
10.3.2.2.2. By Disease Type
10.3.2.2.3. By End User
10.3.3. UAE Alternative Cancer Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapy Type
10.3.3.2.2. By Disease Type
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.1.1 Growing Prevalence of Cancer
11.1.2 Growing Healthcare Expenditure
11.2. Challenges
11.2.1 Lack of Awareness about New Therapies
11.2.2 High Cost of Treatment
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. GLOBAL ALTERNATIVE CANCER THERAPEUTICS MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.6. SWOT Analysis
15.6.1. Innovative Medicine, LLC
15.6.2. Northwest Natural Health Clinic
15.6.3. Immunotherapy Institute
15.6.4. Georgia Cancer Specialists
15.6.5. Holistic Bio Spa
15.6.6. Johnson & Johnson
15.6.7. Celgene Corporation
15.6.8. Astellas Pharma, Inc.
15.6.9. Novartis AG
15.6.10. Merck KGaA
16. STRATEGIC RECOMMENDATIONS
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL ALTERNATIVE CANCER THERAPEUTICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
5.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
5.2.3. By End Users (Hospitals and Clinics, Cancer and Radiation Therapy Center, Home Care, Others)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Product Map
5.3.1. By Therapy Type
5.3.2. By Disease Type
5.3.3. By End Users
5.3.4. By Region
6. NORTH AMERICA ALTERNATIVE CANCER THERAPEUTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
6.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
6.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Alternative Cancer Therapeutics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Therapy Type
6.3.1.2.2. By Disease Type
6.3.1.2.3. By End User
6.3.2. Canada Alternative Cancer Therapeutics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Therapy Type
6.3.2.2.2. By Disease Type
6.3.2.2.3. By End User
6.3.3. Mexico Alternative Cancer Therapeutics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Therapy Type
6.3.3.2.2. By Disease Type
6.3.3.2.3. By End User
7. EUROPE ALTERNATIVE CANCER THERAPEUTICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
7.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
7.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Alternative Cancer Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapy Type
7.3.1.2.2. By Disease Type
7.3.1.2.3. By End User
7.3.2. Germany Alternative Cancer Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapy Type
7.3.2.2.2. By Disease Type
7.3.2.2.3. By End User
7.3.3. United Kingdom Alternative Cancer Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapy Type
7.3.3.2.2. By Disease Type
7.3.3.2.3. By End User
7.3.4. Italy Alternative Cancer Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Therapy Type
7.3.4.2.2. By Disease Type
7.3.4.2.3.
7.3.4.2.4. By End User
7.3.5. Spain Alternative Cancer Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Therapy Type
7.3.5.2.2. By Disease Type
7.3.5.2.3. By End User
8. ASIA-PACIFIC ALTERNATIVE CANCER THERAPEUTICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
8.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
8.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Alternative Cancer Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapy Type
8.3.1.2.2. By Disease Type
8.3.1.2.3. By End User
8.3.2. India Alternative Cancer Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapy Type
8.3.2.2.2. By Disease Type
8.3.2.2.3. By End User
8.3.3. Japan Alternative Cancer Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapy Type
8.3.3.2.2. By Disease Type
8.3.3.2.3. By End User
8.3.4. South Korea Alternative Cancer Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapy Type
8.3.4.2.2. By Disease Type
8.3.4.2.3. By End User
8.3.5. Australia Alternative Cancer Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapy Type
8.3.5.2.2. By Disease Type
8.3.5.2.3. By End User
9. SOUTH AMERICA ALTERNATIVE CANCER THERAPEUTICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
9.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
9.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Alternative Cancer Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapy Type
9.3.1.2.2. By Disease Type
9.3.1.2.3. By End User
9.3.2. Argentina Alternative Cancer Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapy Type
9.3.2.2.2. By Disease Type
9.3.2.2.3. By End User
9.3.3. Colombia Alternative Cancer Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapy Type
9.3.3.2.2. By Disease Type
9.3.3.2.3. By End User
10. MIDDLE EAST AND AFRICA ALTERNATIVE CANCER THERAPEUTICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
10.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
10.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Alternative Cancer Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapy Type
10.3.1.2.2. By Disease Type
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Alternative Cancer Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapy Type
10.3.2.2.2. By Disease Type
10.3.2.2.3. By End User
10.3.3. UAE Alternative Cancer Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapy Type
10.3.3.2.2. By Disease Type
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.1.1 Growing Prevalence of Cancer
11.1.2 Growing Healthcare Expenditure
11.2. Challenges
11.2.1 Lack of Awareness about New Therapies
11.2.2 High Cost of Treatment
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. GLOBAL ALTERNATIVE CANCER THERAPEUTICS MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.6. SWOT Analysis
15.6.1. Innovative Medicine, LLC
15.6.2. Northwest Natural Health Clinic
15.6.3. Immunotherapy Institute
15.6.4. Georgia Cancer Specialists
15.6.5. Holistic Bio Spa
15.6.6. Johnson & Johnson
15.6.7. Celgene Corporation
15.6.8. Astellas Pharma, Inc.
15.6.9. Novartis AG
15.6.10. Merck KGaA
16. STRATEGIC RECOMMENDATIONS
